Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Splash expands its exclusive global license for CannEpil® to include veterinary applications, creating a second regulated pharmaceutical development platfo
-
Noom Health is partnering with Levrx to optimize metabolic health/ GLP-1 programs directly through existing pharmacy benefit platforms
-
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears...
-
Oktopi has received follow-on funding from the Gates Foundation, extending its original grant to advance OktoPilot, the platform's AI-agent
-
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
-
Funding to advance AI-native drug R&D engine and pipelines, including MDR-001, an oral GLP-1 small-molecule in Phase III clinical trials in China.
-
Austin, TX, USA, July 01, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Human Fibrinogen Concentrate Market Size, Trends and Insights By Form...
-
Regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the bio
-
New Autism Research to be Presented at European Purine Scientific Meeting by Marvel Biosciences Collaborators at iBrain Institute in Tours France
-
CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion...